NASDAQ:TTOO T2 Biosystems (TTOO) Stock Price, News & Analysis $0.0007 0.00 (0.00%) As of 12:29 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsInsider TradesSEC Filings About T2 Biosystems Stock (NASDAQ:TTOO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get T2 Biosystems alerts:Sign Up Key Stats Today's Range$0.0007▼$0.000750-Day Range N/A52-Week Range$0.00▼$0.05Volume117 shsAverage Volume9,255 shsMarket Capitalization$14.73 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview T2 Biosystems, Inc. is a medical technology company that develops diagnostic products for the rapid detection of sepsis-causing pathogens and antimicrobial resistance. The company’s tests are designed to identify infections directly from blood samples, helping healthcare professionals make treatment decisions more quickly than traditional culture-based methods. The company’s product portfolio is built around the T2Dx Instrument, an automated diagnostic platform that uses T2 Magnetic Resonance technology. Its offerings have included T2Bacteria and T2Candida panels for detecting bacterial and fungal pathogens associated with bloodstream infections, as well as tests designed to identify certain antimicrobial-resistance markers. T2 Biosystems has also developed products aimed at detecting organisms and resistance genes relevant to public-health and hospital-infection settings. Founded in 2006 and headquartered in Lexington, Massachusetts, T2 Biosystems markets its diagnostic systems primarily to hospitals, clinical laboratories and other healthcare institutions. Its technology is intended to support faster diagnosis and more targeted antimicrobial therapy in the management of sepsis and other serious infections.AI Generated. May Contain Errors. Read More Receive TTOO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for T2 Biosystems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TTOO Stock News HeadlinesT2 Biosystems (NASDAQ:TTOO) Share Price Breaks Above 50-Day Moving Average - Should You Sell?October 15 at 3:41 AM | americanbankingnews.comT2 Biosystems Inc.May 19, 2026 | marketwatch.comElon says the ‘S’ wordElon Musk and Sam Altman have sued each other and feuded for years. Yet within days of one another, both men described the same moment in strikingly similar terms: a technological tipping point they call the Singularity. James Altucher says the idea once belonged to science fiction. Now he connects it to a move Musk could make as soon as October 21, and lays out what both men see coming in a short presentation.October 16 at 1:00 AM | Paradigm Press (Ad)T2 Biosystems, Inc. Announces Intent to Complete Winding Down of OperationsFebruary 3, 2026 | finance.yahoo.comT2 Biosystems Inc. (TTOO): 2025 Product Pipeline and Strategy Analysis ReportOctober 21, 2025 | finance.yahoo.comTTOO T2 Biosystems, Inc. - Seeking AlphaJune 25, 2025 | seekingalpha.comT2 Biosystems Inc. (TTOO) After Hours QuoteJune 10, 2025 | nasdaq.comT2 Biosystems initiates major layoffs, seeks asset saleFebruary 22, 2025 | uk.investing.comSee More Headlines TTOO Stock Analysis - Frequently Asked Questions How have TTOO shares performed this year? T2 Biosystems' stock was trading at $0.0050 on January 1st, 2026. Since then, TTOO shares have decreased by 86.0% and is now trading at $0.0007. How were T2 Biosystems' earnings last quarter? T2 Biosystems, Inc. (NASDAQ:TTOO) announced its earnings results on Monday, July, 29th. The medical equipment provider reported ($0.66) earnings per share for the quarter, beating the consensus estimate of ($0.97) by $0.31. The medical equipment provider earned $1.95 million during the quarter. Read the conference call transcript. When did T2 Biosystems' stock split? T2 Biosystems shares reverse split before market open on Friday, October 13th 2023.The 1-100 reverse split was announced on Friday, October 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. When did T2 Biosystems IPO? T2 Biosystems (TTOO) raised $83 million in an initial public offering on Wednesday, August 6th 2014. The company issued 5,200,000 shares at $15.00-$17.00 per share. How do I buy shares of T2 Biosystems? Shares of TTOO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of T2 Biosystems own? Based on aggregate information from My MarketBeat watchlists, some other companies that T2 Biosystems investors own include Bionano Genomics (BNGO), Tesla (TSLA), NIO (NIO), Sorrento Therapeutics (SRNE), NVIDIA (NVDA), SNDL (SNDL) and Canopy Growth (CGC). Company Calendar Last Earnings7/29/2024Today10/16/2026Next Earnings (Estimated)11/13/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:TTOO CIK1492674 Webwww.t2biosystems.com Phone(781) 761-4646Fax781-357-3080Employees113Year Founded2006Profitability EPS (Trailing Twelve Months)($3.89) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$50.08 million Net Margins-563.16% Pretax Margin-559.52% Return on EquityN/A Return on Assets-174.06% Debt Debt-to-Equity RatioN/A Current Ratio0.40 Quick Ratio0.24 Sales & Book Value Annual Sales$7.68 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($6.91) per share Price / Book0.00Miscellaneous Outstanding Shares21,043,000Free Float21,037,000Market Cap$14.73 thousand OptionableNo Data Beta8.13 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:TTOO) was last updated on 10/16/2026 by MarketBeat.com Staff. From Our PartnersA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...Weiss Ratings | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
